Medicilon(SH:688202) Zheng Quan Zhi Xing·2025-08-29 17:15Core Points - Shanghai Medicilon Biopharmaceutical Co., Ltd. is convening its second extraordinary general meeting of shareholders in 2025 on September 15, 2025 [1][3] - The meeting will utilize a combination of on-site and online voting methods [1][4] - The agenda includes proposals for new projects, permanent supplementary working capital, and matters related to the incentive plan [2][8] Meeting Details - The meeting will take place at the company's office located at 585 Chuan Da Road, Pudong New District, Shanghai [1][3] - Voting will be conducted through the Shanghai Stock Exchange's online voting system, with specific time slots for trading and internet voting [1][4] - Shareholders must register to attend the meeting, with specific documentation required for both individual and corporate shareholders [5][6] Voting Procedures - Shareholders can vote via the Shanghai Stock Exchange's online voting system or in person, with the first vote counted in case of multiple submissions [4][6] - The voting rights are available to shareholders registered by the close of business on September 8, 2025 [5] - Proxy voting is allowed, and specific forms must be completed for representation [8]